IDEXX Laboratories Inc. (IDXX)
NASDAQ: IDXX
· Real-Time Price · USD
631.19
-2.65 (-0.42%)
At close: Oct 03, 2025, 3:59 PM
631.18
0.00%
After-hours: Oct 03, 2025, 05:06 PM EDT
-0.42% (1D)
| Bid | 621.48 |
| Market Cap | 50.5B |
| Revenue (ttm) | 4.04B |
| Net Income (ttm) | 985.66M |
| EPS (ttm) | 11.78 |
| PE Ratio (ttm) | 53.58 |
| Forward PE | 43.82 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 650 |
| Volume | 323,682 |
| Avg. Volume (20D) | 551,652 |
| Open | 637.01 |
| Previous Close | 633.84 |
| Day's Range | 627.89 - 642.25 |
| 52-Week Range | 356.14 - 688.12 |
| Beta | 1.58 |
| Ex-Dividend Date | n/a |
About IDXX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IDXX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IDXX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsIDEXX Laboratories Inc. is scheduled to release its earnings on
Oct 30, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+27.49%
IDEXX Laboratories shares are trading higher after...
Unlock content with
Pro Subscription
5 months ago
+8.95%
IDEXX Laboratories shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 EPS guidance above estimates. Also, the company raised its FY25 sales guidance with its midpoint above estimates.
